Navigation Links
Johnson & Johnson Announces Definitive Agreement to Acquire Cougar Biotechnology, Inc.
Date:5/21/2009

tive ideas, products and services to advance the health and well-being of people. Our approximately 119,000 employees at more than 250 Johnson & Johnson companies work with partners in health care to touch the lives of over a billion people every day, throughout the world.

About Ortho Biotech Oncology Research & Development

Ortho Biotech Oncology Research & Development, a unit of Centocor Research & Development, Inc., a Johnson & Johnson company, is a research and development organization dedicated to oncology, hematology and supportive care. It partners closely with Centocor Ortho Biotech Products, L.P. and Janssen-Cilag companies worldwide to bring oncology treatments and supportive medicines to patients around the world.

About Cougar Biotechnology, Inc.

Cougar Biotechnology is a Los Angeles-based biotechnology company, established to in-license and develop clinical stage drugs, with a specific focus on the field of oncology. Cougar Biotechnology's oncology portfolio includes abiraterone acetate (CB7630), an orally available targeted inhibitor of the steroidal enzyme known as 17-alpha hydroxylase/C17,20 lyase, which is currently being studied in two Phase III clinical trials in prostate cancer and a Phase I/II trial in breast cancer; noscapine (CB3304), an inhibitor of microtubule dynamics, which is currently in a Phase I trial in multiple myeloma; and seocalcitol (CB1089), an analog of vitamin D, which has been clinically tested in a number of solid tumor types. Further information about Cougar Biotechnology can be found at www.cougarbiotechnology.com.

(This press release contains "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995. These statements are based on current expectations of future events. If underlying assumptions prove inaccurat
'/>"/>

SOURCE Johnson & Johnson
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Simbionix and Johnson & Johnson LLC Announce a Distribution Agreement for Russia and the CIS Countries
2. Burnham Announces Assay Development and License Agreement with Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
3. Johnson & Johnson Completes Acquisition of Omrix Biopharmaceuticals, Inc.
4. Johnson & Johnson Announces Definitive Agreement to Acquire Omrix
5. Cynvec LLC(SM) Appoints Former Johnson & Johnson Executive Frank D. Stonebanks as President and Chief Executive Officer
6. Johnson & Johnson Pharmaceutical Research & Development, L.L.C. Submits New Drug Application to FDA for Carisbamate
7. Sustainable Oils Names Scott Johnson as General Manager, Expands Management Team for Camelina Research and Production
8. Johnson & Johnson Honors 2008 Recipients of The Dr. Paul Janssen Award for Biomedical Research
9. Migenix averts proxy contest; reaches agreement with DJohnson holdings
10. Craig Johnson Joins Ardea Biosciences Board of Directors
11. Ortho Biotech Oncology Research & Development Unites Johnson & Johnson Biopharmaceutical Oncology R&D Assets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)...  BioSpecifics Technologies Corp. (NASDAQ: BSTC ... collagenase-based products marketed as XIAFLEX ® (collagenase ... XIAPEX ® in the EU, today announced ... Phase 2a study of CCH for the potential ... results showed that all three doses of CCH ...
(Date:8/21/2014)... Institute for Molecular Medicine Finland (FIMM), University of ... novel "man and machine" decision support system for ... described in PLOS One scientific journal ... computer vision algorithms similar to those used in ... the diagnostically most relevant areas. Tablet computers can ...
(Date:8/21/2014)... 21, 2014 2014 Deep ... is a professional and in-depth research report ... provides basic Seaweed Fertilizer information, including Seaweed ... structure as well as industry overview. This ... domestic market as well as global industry ...
(Date:8/21/2014)... Emmetsburg, IA (PRWEB) August 21, 2014 ... Project LIBERTY Opening , The Court of His Majesty ... King will attend the Grand Opening of POET-DSM Advanced ... on Wednesday, Sept. 3. , The King will take ... formal opening activity, scheduled for 11 a.m.-12:20 p.m. and ...
Breaking Biology Technology:BioSpecifics Technologies Corp. Announces Positive Data from Phase 2a Study of CCH for Treatment of Cellulite 2BioSpecifics Technologies Corp. Announces Positive Data from Phase 2a Study of CCH for Treatment of Cellulite 3BioSpecifics Technologies Corp. Announces Positive Data from Phase 2a Study of CCH for Treatment of Cellulite 4BioSpecifics Technologies Corp. Announces Positive Data from Phase 2a Study of CCH for Treatment of Cellulite 5A novel 'man and machine' decision support system makes malaria diagnostics more effective 2Internationals Seaweed Fertilizer Industry 2014 Development Trend Analysis in New Research Study at DeepResearchReports.com 2Internationals Seaweed Fertilizer Industry 2014 Development Trend Analysis in New Research Study at DeepResearchReports.com 3His Majesty Willem-Alexander, King of the Netherlands, to Attend Project LIBERTY opening 2His Majesty Willem-Alexander, King of the Netherlands, to Attend Project LIBERTY opening 3
... Commission,s Joint Research Centre (JRC) has just launched ... representative range of 25 different types of reference ... consumer protection and confidence in many innovative applications ... promising technological developments. By enabling a harmonised risk ...
... CANTEL MEDICAL CORP. (NYSE: CMN ), through ... prevention and control business by purchasing the sterilization monitoring ... Colorado, ConFirm is one of the leading providers of ... ConFirm offers both a mail-in service and in-office spore ...
... LONG BRANCH, N.J., Feb. 14, 2011 Pharma ChemOutsourcing ... the first wave of 50 speakers from a diverse ...   "The biotechs all have clinical ... limited capital and human resources demonstrate how they have ...
Cached Biology Technology:Small material, big impact 2Cantel Medical Acquires the Sterilization Monitoring Business of ConFirm Monitoring Systems, Inc. 2Cantel Medical Acquires the Sterilization Monitoring Business of ConFirm Monitoring Systems, Inc. 3Pharma ChemOutsourcing 2011 Unveils First Wave of 50 Biotech Chemist Speakers for September 12-15 Show in New Jersey 2
(Date:8/21/2014)... to ignore, but they are the ultimate source of ... are increasingly dependent on algae, too, to suck up ... to the bottom of the ocean. Now, by using ... have evidence showing that viruses infecting those algae are ... when all else stays essentially the same, and this ...
(Date:8/21/2014)... Nine researchers from Beth Israel Deaconess Medical Center (BIDMC ... World,s Most Influential Scientific Minds 2014," a comprehensive ... a web resource for science metrics and research performance ... the most influential "are performing and publishing work that ... their science," according to a Thomson Reuters statement. Researchers ...
(Date:8/21/2014)... to Wednesday, Oct. 18-22, 2014 , WHERE: ... Drive, San Diego, CA 92101 , WHAT: ... presentations of the latest research in human genetics. ... featuring high-scoring abstracts on rare genetic variants in ... and treatment for sun sensitivity (Saturday, Oct. 18, ...
Breaking Biology News(10 mins):Viruses take down massive algal blooms, with big implications for climate 2BIDMC researchers named among 'the most influential scientific minds' 2BIDMC researchers named among 'the most influential scientific minds' 3American Society of Human Genetics 2014 Annual Meeting 2
... antibiotic appears to be a safe treatment for stroke and ... is currently the only FDA-approved drug therapy, researchers report. ... and Oregon found the drug well tolerated even at three-and-one-half ... arthritis, according to a research team led by the Medical ...
... flowers to produce pretty petals or sweet scents now ... new types of flowers. DNA analysis of wild evergreen ... of the plant could be derived from hybrids cross-breeds ... the rich biodiversity of the natural world, as it shows ...
... carbon nanotubes (hollow tubes of carbon atoms), MIT chemical ... 100 times more than a regular photovoltaic cell. Such ... energy, potentially allowing much smaller and more powerful solar ... a photovoltaic cell, you could have little spots that ...
Cached Biology News:Antibiotic appears safe for stroke patients and good companion for tPA 2Antibiotic appears safe for stroke patients and good companion for tPA 3Nature's gift for gardening may hold key to biodiversity 2MIT researchers develop a way to funnel solar energy 2MIT researchers develop a way to funnel solar energy 3